SARA BAGHERIHUT: Open Payments
NPI 1992561229 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $287 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $260 |
| GENZYME CORPORATION | 3 | $101 |
| Amgen Inc. | 5 | $96 |
| ABBVIE INC. | 3 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| UCB, Inc. | 1 | $39 |
| Janssen Biotech, Inc. | 1 | $32 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $30 |
| Journey Medical Corporation | 1 | $14 |
Products named: DUPIXENT, OTEZLA, SKYRIZI, Bimzelx, LIBTAYO, ILUMYA, Winlevi, TREMFYA.
Industry payments across IL — which companies pay providers there.
